Univercells and Takeda Pharmaceutical Company Limited together to Produce Affordable Vaccines for All

We are excited to announce a new chapter in Univercells’ story. By closing a €3M investment with Takeda Pharmaceutical Company, Limited, through its strategic venture arm Takeda Ventures, Inc., we are making a huge step towards biologics for all. Together, we will launch a development program to adapt Univercells’ new generation continuous integrated manufacturing methods to make Takeda’s vaccines available to people in need. Wherever they may live.

Download the Press Release EN / FR / NL